This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
This approval has come from the company's finished dosage form manufacturing facility
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Robots make it to the healthcare conference panel, reflecting the future potential of technology
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
